首页 > 市场调查报告书 > 医疗设备

医学影像诊断

市场调查报告书

商品编码

1560822

全球诊断影像设备市场 - 2024 - 2031

Global Diagnostic Imaging Equipment Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球诊断影像设备市场2023年达到445亿美元，预计到2031年将达到660.6亿美元，2024-2031年预测期间复合年增长率为5.2%。

诊断影像描述了观察身体内部的各种技术，以帮助找出疾病或受伤的原因并确认诊断。诊断健康影像技术已经改变了医疗保健，现在可以更早诊断医疗状况，减少不必要的侵入性探索过程的需要，并创造更好的患者治疗结果。诊断影像技术应用于骨科、神经科、妇产科、肿瘤学、心臟科、牙科等各个医学领域。

诊断影像是一种非侵入性影像测试的医疗技术，透过获取患者身体内部结构和器官的视觉影像来诊断和监测疾病或损伤。医生广泛使用诊断影像技术来检查和诊断患者的确切医疗状况。它有助于识别心臟异常、骨折、动脉瘤、胃肠道问题和各种类型的癌症。诊断影像也用于监测患者的身体对治疗的反应。诊断影像可以及早诊断疾病并显着改善患者的生存结果。这是一种无痛技术，可提供快速诊断。诊断影像产业已经发生了从床边监测到高阶数位扫描的彻底变革。

市场动态：

司机

慢性病盛行率增加

各种慢性病盛行率的上升推动了市场的成长。例如，根据 nih.gov 2023 年 1 月发表的一篇文章，预计 2023 年美国将出现 1,958,310 例新癌症病例和 609,820 例癌症死亡。在经历了二十年的下降之后，从 2014 年到 2019 年，前列腺癌的发生率每年增加 3%，意味着新增病例增加了 99,000 例。

此外，根据wcrf.org 的数据，包括非黑色素瘤皮肤癌(NMSC) 在内，2022 年全球癌症病例数为19,976,499 例。男性女性 9,175,141 人。此外，根据 IARC 的数据，2022 年将有近 2,000 万新发癌症病例（包括非黑色素瘤皮肤癌 [NMSC]），同时有 970 万人死于癌症（包括 NMSC）。据估计，大约五分之一的男性或女性一生中会罹患癌症，而大约九分之一的男性和十二分之一的女性会死于癌症。肺癌是 2022 年最常被诊断出的癌症，导致近 250 万新病例，即全球八分之一的癌症之一（占全球所有癌症的 12.4%）。

限制

治疗相关的高成本、缺乏医疗基础设施以及缺乏熟练专业人员等因素预计将阻碍市场。

细分市场分析

全球诊断成像设备市场根据产品类型、应用、最终用户和地区进行细分。

X光约占全球诊断影像设备市场占有率的48.6%

X 射线领域预计将在预测期内占据最大的市场份额。在这一领域，技术进步推动了这个市场。

X 射线是电磁辐射的一种形式，类似于可见光。然而，与光不同的是，X 射线具有更高的能量，可以穿过大多数物体，包括身体。医用 X 光用于产生体内组织和结构的图像。如果穿过身体的 X 光也穿过病人另一侧的 X 光侦测器，就会形成代表体内物体形成的「阴影」的影像。

例如，2024 年 1 月，Carestream Health 推出了一款名为 DXR-Excel Plus 的新型 X 光系统，其功能旨在帮助简化工作流程并提高生产力。 DXR-Excel Plus 是一款适用于萤光透视和普通放射学的二合一系统，可为各种检查提供即时影像，同时提供有助于为使用者、患者和管理员创造增强体验的功能。

市场地域占有率

北美约占全球诊断影像设备市场份额的42.8%

预计北美地区将在预测期内占据最大的市场份额。该地区慢性病发病率的上升和技术进步有助于推动市场发展。

例如，根据 nih.gov 2024 年 1 月发表的一篇文章，预计 2024 年美国将出现 2,001,140 例新癌症病例和 611,720 例癌症死亡。到 2021 年，癌症死亡率持续下降，由于吸烟的减少、某些癌症的早期发现以及辅助和转移治疗方案的改进，自 1991 年以来避免了超过 400 万人死亡。然而，这些成果受到十大癌症中六种发病率上升的威胁。

此外，2024 年 6 月，史密斯探测推出了采用衍射技术 SDX 10060 XDi 的最新 X 光扫描仪。 X 射线衍射 (XRD) 是一种强大的检测技术，可根据物体的分子结构提供高精度的材料辨别和物质识别。 XRD 特别适合检测不断变化的粉末、液体或固体形式的化合物，例如「自製」爆炸物或麻醉剂，甚至对于密度相似的材料也是如此。

Diagnostic imaging describes various techniques of viewing the inside of the body to help figure out the causes of an illness or injury and confirm a diagnosis. Diagnostic health imaging technology has transformed healthcare and now allows for earlier diagnosis of medical conditions, reduces the need for needless invasive exploratory processes, and creates better patient outcomes. Diagnostic imaging technology is applied in various fields of medicine like orthopedics, neurology, obstetrics/gynecology, oncology, cardiology, dental, and others.

Diagnostic imaging is a medical technique of non-invasive imaging tests for diagnosing and monitoring diseases or injuries by getting visual images of internal structures and organs of the patient's body. Diagnostic imaging technologies are used extensively by doctors to examine and diagnose the exact medical conditions of patients. It helps identify cardiac abnormalities, broken bones, aneurysms, gastrointestinal issues, and various types of cancer. Diagnostic imaging is also used to monitor how the patient's body responds to the treatment being given. Diagnostic imaging diagnoses disease early and significantly improves patient survival outcomes. It is a painless technique and offers a rapid diagnosis. The diagnostic imaging industry has been revolutionized from bedside monitoring to high-end digital scanning.

Market Dynamics: Drivers

Increasing prevalence of chronic diseases

The rising prevalence of various chronic diseases propels the market growth. For instance, according to an article published by nih.gov in January 2023, in 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases.

Moreover, according to wcrf.org, including non-melanoma skin cancer (NMSC) there were 19,976,499 cancer cases in 2022. When NMSC was excluded, this number dropped to 18,741,966 cancer cases around the world in 2022. Of these, 9,566,825 were in men and 9,175,141 in women. Moreover, according to IARC, There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally).

Restraints

Factors such as high cost associated with the treatment, lack of healthcare infrastructure, and shortage of skilled professionals are expected to hamper the market are expected to hamper the market.

Market Segment Analysis

The global diagnostic imaging equipment market is segmented based on product type, application, end-user, and region.

The X-ray accounted for approximately 48.6% of the global diagnostic imaging equipment market share

The X-ray segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements drive this market.

X-rays are a form of electromagnetic radiation, similar to visible light. Unlike light, however, x-rays have higher energy and can pass through most objects, including the body. Medical X-rays are used to generate images of tissues and structures inside the body. If X-rays traveling through the body also pass through an X-ray detector on the other side of the patient, an image will be formed that represents the "shadows" formed by the objects inside of the body.

For instance, in January 2024, Carestream Health launched a new x-ray system called DXR-Excel Plus with features designed to help simplify workflow and enhance productivity. DXR-Excel Plus is a two-in-one system for both fluoroscopy and general radiology that delivers real-time, images for a wide range of exams while providing features that help create an enhanced experience for users, patients, and administrators.

Market Geographical Share

North America accounted for approximately 42.8% of the global diagnostic imaging equipment market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of chronic diseases, and technological advancements, in this region, help to propel the market.

For instance, according to an article published by nih.gov in January 2024, 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers.

Moreover, in June 2024, Smiths Detection launched its latest X-ray scanner powered by diffraction technology SDX 10060 XDi. X-ray Diffraction (XRD) is a powerful inspection technology offering highly accurate material discrimination and substance identification based on an object's molecular structure. XRD is particularly suited to detecting constantly evolving compounds in powder, liquid, or solid forms, such as 'homemade' explosives or narcotics, even for materials with similar densities.

Market Segmentation

By Product Type

X-ray

Computed Tomography

Ultrasound

Magnetic Resonance Imaging

Nuclear Imaging

Tactile Imaging

Photoacoustic Imaging

Thermography

Elastography

Echocardiography

Functional Near-Infrared Spectroscopy

Mammography

By Application

Cardiology

Orthopedics

Gastroenterology

Gynecology

Oncology

Neurology

Others

By End-User

Hospitals And Clinics

Diagnostic Imaging Centers

Other

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the global diagnostic imaging equipment market include GE Healthcare, Shimadzu Corporation, Philips Healthcare, Genesis Medical Imaging Inc., Hologic Inc., Siemens Healthcare, Samsung Medison Co. Ltd, Carestream Health Inc., Hitachi Medical Corporation and Toshiba Corporation among others.

Key Developments

In February 2024, Philips Healthcare announced the launch of a new light-based catheter guidance system for cath labs that represents a step toward radiation-free interventional imaging. The focus of the technology right now is endovascular aortic procedures.

In March 2024, Philips Healthcare introduced a new computed tomography system this week at the European Congress of Radiology (ECR) aimed at the rapidly growing cardiac coronary CT angiography (CCTA) market. It features a new detector that was designed to optimize the use of artificial intelligence (AI) image reconstruction algorithms. The new CT 5300 system provides more accurate and reliable imaging results to better manage the increase in complex cardiac cases.

In February 2024, A&M Life Solutions, a certified public procurement supplier of medical devices/healthcare services in collaboration with Fujifilm, launched a mobile X-ray device into the market known as the Fujifilm Xair, the device is a mobile X-ray solution with AI, mainly for Occupational Healthcare. It can generate reports on site for most communicable diseases such as Tuberculosis (TB), COVID-19, etc for chest-related issues, extremities, and emergencies or accident X-ray diagnoses.

Why Purchase the Report?

To visualize the global diagnostic imaging equipment market segmentation based on product type, application, end-user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global diagnostic imaging equipment market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global diagnostic imaging equipment market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Chronic Diseases
- 4.1.2. Restraints
  - 4.1.2.1. High Cost Associated with Procedures
  - 4.1.2.2. Lack of Healthcare Infrastructure
  - 4.1.2.3. Shortage of Skilled Professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. X-Ray*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Computed Tomography
6.4. Ultrasound
6.5. Magnetic Resonance Imaging
6.6. Nuclear Imaging
6.7. Tactile Imaging
6.8. Photoacoustic Imaging
6.9. Thermography
6.10. Elastography
6.11. Echocardiography
6.12. Functional Near Infrared Spectroscopy
6.13. Mammography

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Cardiology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Orthopedics
7.4. Gastroenterology
7.5. Gynecology
7.6. Oncology
7.7. Neurology
7.8. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals and Clinics*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Imaging Centers
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. GE Healthcare *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Shimadzu Corporation
11.3. Koninklijke Philips N.V
11.4. Genesis Medical Imaging Inc.
11.5. Hologic Inc.
11.6. Siemens Healthcare
11.7. Samsung Medison Co. Ltd.
11.8. Carestream Health Inc.
11.9. Hitachi Medical Corporation
11.10. Toshiba Corporation (*LIST NOT EXHAUSTIVE)